1078-1079 / 1578
Unresectable CRLM Local treatment
•
Phase II study in unresectable colorectal liver–limited metastases
•
Randomised to systemic treatment alone (
standard arm
) or systemic
treatment plus local treatment by RFA +/- resection (
experimental arm -
CMT
)
•
Primary end point: 30-month OS rate higher than 38% in CMT arm
•
119 patients were randomized
CRLM - colorectal liver metastases
Ruers T, JNCI 2017